Skip to main content
. Author manuscript; available in PMC: 2018 Dec 28.
Published in final edited form as: J Control Release. 2017 Oct 13;268:49–56. doi: 10.1016/j.jconrel.2017.10.006

Figure 3. Phage screening on nanosystem-treated tumors.

Figure 3

(A) Schematic showing steps in the phage screening. (B) A sampling of then top 20 motifs among the most frequent 200 4-amino acid motifs in responding and non-responding tumors. X-denotes any amino acid. Only full-length (cyclic) inserts were considered.